prof. dr. apr. Niek Sanders
- Work address
-
Heidestraat 19
9820 Merelbeke - Niek.Sanders@UGent.be
- ORCID iD
-
0000-0003-4585-0343
Show
Sort by
-
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer
-
One cisplatin dose suffices to maintain anti-tumor immunity and enhances anti-PD-1 efficacy in an intraductal model for triple-negative breast cancer
(2022) -
- Journal Article
- A1
- open access
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
-
Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer
-
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across
-
- Miscellaneous
- open access
Low-dose single-shot COVID-19 mRNA vaccines lie ahead
-
In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation
-
- Journal Article
- A1
- open access
Mucosal vaccination against periodontal disease : current status and opportunities
-
- Journal Article
- A1
- open access
Antibody-mediated targeting of antigens to intestinal aminopeptidase N elicits gut IgA responses in pigs
-
- Journal Article
- A1
- open access
Squaric ester-based, pH-degradable nanogels : modular nanocarriers for safe, systemic administration of toll-like receptor 7/8 agonistic immune modulators